Spinal muscular atrophy (SMA) is a genetic neuromuscular disease affecting specialized nerve cells that control voluntary muscle movement, according to the Muscular Dystrophy Association (MDA). It can ...

A comprehensive review details how three FDA-approved therapies have dramatically improved spinal muscular atrophy outcomes ...

CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Sep 11, 2026-- ...

Newswise — A new clinical trial has revealed encouraging results for a muscle-targeting therapy aimed at improving motor function in children and adolescents with spinal muscular atrophy, according to ...

Cachexia is one of the most severe forms of muscle wasting in humans. It affects up to 80% of cancer patients and is caused ...

Restoring just part of a depleted mitochondrial fat began reversing muscle wasting in mice, suggesting a possible route toward treating age-related muscle decline.

Please provide your email address to receive an email when new articles are posted on . Isembyld is approved for all adults and children aged 2 years and older. In a trial, participants saw a gain of ...

A retrospective study of nearly 300 kidney cancer patients links bone metastases to dramatically accelerated skeletal muscle loss and sharply reduced survival, highlighting the bone as a potential ...

A research team from biotech startup TreeOne announced on the 19th that it has proposed a candidate biomarker panel to track ...

Biotechs developing therapeutics to treat rare diseases include two that received FDA approvals this year for drugs to treat ...